HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 15 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $509,736 | +258649.2% | 656,453 | 0.0% | 0.00% | – |
| Q4 2022 | $197 | -99.9% | 656,453 | -0.3% | 0.00% | – |
| Q3 2022 | $332,000 | -11.7% | 658,110 | 0.0% | 0.00% | – |
| Q2 2022 | $376,000 | -55.7% | 658,110 | 0.0% | 0.00% | – |
| Q1 2022 | $848,000 | +13.1% | 658,110 | 0.0% | 0.00% | – |
| Q4 2021 | $750,000 | -25.4% | 658,110 | 0.0% | 0.00% | – |
| Q3 2021 | $1,006,000 | -22.0% | 658,110 | +1.0% | 0.00% | – |
| Q2 2021 | $1,289,000 | +19.0% | 651,318 | +10.6% | 0.00% | – |
| Q1 2021 | $1,083,000 | +144.5% | 588,718 | +190.6% | 0.00% | – |
| Q4 2020 | $443,000 | +804.1% | 202,555 | +1183.1% | 0.00% | – |
| Q3 2020 | $49,000 | -66.9% | 15,786 | -43.3% | 0.00% | – |
| Q4 2019 | $148,000 | – | 27,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 189,616 | $375,439,000 | 1.17% |
| Ikarian Capital, LLC | 1,365,059 | $2,703,000 | 0.22% |
| Altium Capital Management LP | 446,000 | $883,000 | 0.20% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 91,500 | $181,000 | 0.10% |
| Virtu Financial LLC | 113,869 | $225,000 | 0.02% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $20,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 155,069 | $307,000 | 0.01% |
| McAdam, LLC | 55,978 | $86,000 | 0.01% |
| Moloney Securities Asset Management, LLC | 27,340 | $54,000 | 0.01% |
| Allen Capital Group, LLC | 23,685 | $47,000 | 0.01% |